AGIO up +1.07% percent Today $AGIO High is at 88.59 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
AGIO up +1.07% percent Today $AGIO High is at 88.59 and the Low 87.00 with current volume of 125,958.

Recent News posted below.

Agios Pharmaceuticals Inc AGIO other info.
http://investorshangout.com/Agios-Pharmaceuti...GIO-90049/

AGIO Agios Pharmaceuticals Inc Recent Headline News

Jim Cramer Says to Buy Six Flags, Avoid SeaWorld Entertainment
at The Street - Wed Nov 12, 1:20PM CST
TheStreet's Jim Cramer says investors shouldn't be tricked by SeaWorld's attractive dividend yield. Instead, stick with Six Flags Entertainment.
SEAS: 16.89 (+0.04), SIX: 40.65 (-0.22), AGIO: 86.73 (-0.14)

Nasdaq stocks posting largest percentage increases
AP - Tue Nov 11, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
ICUI: 84.02 (-0.71), OREX: 5.95 (+0.11), PCMI: 8.83 (+0.03), CYAN: 6.14 (+0.16), ACHN: 13.90 (-0.95), TGTX: 14.37 (+0.34), AGIO: 86.73 (-0.14), LIOX: 5.33 (-0.10), SAJA: 6.21 (+0.31), PLNR: 6.80 (-0.35)

Biotech Weekly: When Mid Caps Are Priced Nearly For Perfection
Daniel Ward - at Seeking Alpha - Mon Nov 10, 9:28AM CST

XBI: 173.20 (-0.48), SLXP: 96.65 (+1.10), ICPT: 160.20 (-2.76), IBB: 295.54 (-0.95), AGIO: 86.73 (-0.14)

Agios Pharmaceuticals' (AGIO) CEO David Schenkein on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Nov 08, 6:31AM CST

AGIO: 86.73 (-0.14)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 8:14AM CST

BEBE: 2.42 (-0.05), ANET: 77.52 (+0.28), TKMR: 16.64 (+0.54), ORBC: 6.41 (-0.16), MDRX: 12.36 (+0.41), RMTI: 11.08 (-0.16), CTIC: 2.18 (unch), SHLD: 38.43 (+0.67), UBNT: 28.56 (-0.44), RIG: 26.31 (-0.77), KGC: 2.52 (+0.06), APT: 2.86 (-0.14), ANF: 29.15 (-0.20), MITK: 3.50 (-0.16), ZNGA: 2.77 (-0.04), CNET: 2.08 (-0.07), KING: 15.48 (+1.45), NETE: 1.38 (-0.02), SLXP: 96.65 (+1.10), RPRX: 10.17 (+0.74), NADL: 4.28 (-0.66), PGNX: 6.57 (-0.04), AVNR: 13.31 (+0.13), FSLR: 47.86 (-1.73), DVA: 76.78 (+0.06), NDLS: 23.70 (-0.44), ICPT: 160.20 (-2.76), AGIO: 86.73 (-0.14), PLNR: 6.80 (-0.35)

Agios Pharmaceuticals EPS of $0.10
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 6:11AM CST

AGIO: 86.73 (-0.14)

Agios Pharmaceuticals posts 3Q profit
Automated Insights - Fri Nov 07, 6:09AM CST
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Friday reported earnings of $3.7 million, or 10 cents per share, in its third quarter.
AGIO: 86.73 (-0.14)

Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
GlobeNewswire - Fri Nov 07, 6:00AM CST
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today reported business highlights and financial results for the third quarter ended September 30, 2014.
AGIO: 86.73 (-0.14)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 4:30PM CST

BAM: 49.70 (-0.16), ERF: 14.74 (-0.66), LXP: 11.07 (+0.08), PGEM: 12.86 (-0.16), CCOI: 35.30 (+0.38), TTI: 8.34 (-0.20), SJI: 57.98 (-0.08), NXST: 45.97 (+0.44), VSAT: 65.40 (+1.39), MT: 12.07 (+0.04), LXU: 33.13 (-0.23), HUM: 138.55 (+1.30), PGNX: 6.57 (-0.04), MHR: 4.70 (-0.11), CTB: 32.57 (-0.03), IDRA: 2.48 (-0.08), ISIS: 51.45 (+0.37), BPL: 80.55 (+1.09), SSP: 19.32 (+0.35), AGIO: 86.73 (-0.14), EBIX: 16.38 (-0.18)

Will Agios (AGIO) Disappoint in the Q3 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 4:10PM CST
Agios (AGIO), which is scheduled to report third-quarter results on Nov 7, had delivered a negative earnings surprise of 14.89% in the last quarter.
MNK: 87.25 (-5.74), RNA: 11.60 (-0.15), AGIO: 86.73 (-0.14), CELG: 107.47 (-0.78)

Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
GlobeNewswire - Thu Nov 06, 8:46AM CST
New Data from Ongoing Phase 1 AG-221 Trial Accepted for Oral Presentation
AGIO: 86.73 (-0.14)

Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver
PR Newswire - Mon Nov 03, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for LNKD, IMPV, NSC, HAL and AGIO.
NSC: 115.96 (-0.70), LNKD: 231.27 (+0.14), HAL: 51.64 (-1.59), AGIO: 86.73 (-0.14), IMPV: 44.23 (-0.42)

Super Important Biotech and Drug Stock Events for November
at The Street - Mon Nov 03, 7:24AM CST
A cheat sheet of earnings, medical meetings, FDA approval decisions and clinical trial results for healthcare investors.
GILD: 105.00 (-1.90), CLVS: 56.76 (-1.68), ARWR: 6.36 (-0.17), ACHN: 13.90 (-0.95), MRK: 59.62 (+0.31), RTRX: 11.80 (+0.24), RGLS: 18.35 (-1.27), EPZM: 22.59 (-1.29), AGIO: 86.73 (-0.14), RMTI: 11.08 (-0.16), ARNA: 4.75 (+0.05), KERX: 15.63 (+0.04)

Cramer's Lightning Round - Isis Pharmaceuticals Has The Best Pipeline (10/28/14)
SA Editor Miriam Metzinger - Seeking Alpha - Wed Oct 29, 5:59AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday October 2 8. Bullish Calls: Isis Pharmaceuticals (NASDAQ: ISIS ): "Isis got slammed, and (the selloff) was overdone. It has the best pipeline...
GS: 190.13 (-0.05), RICE: 25.98 (-0.23), ISIS: 51.45 (+0.37), CYBR: 40.64 (+6.94), GNC: 43.70 (-0.52), HAL: 51.64 (-1.59), AGIO: 86.73 (-0.14), FTNT: 27.09 (-0.07)

'Mad Money' Lightning Round: I'm Sticking With Isis Pharmaceuticals
at The Street - Wed Oct 29, 5:00AM CDT
Cramer says Halliburton is a buy, buy, buy and GNC needs to merge with Vitamin Shoppe.
VSI: 48.26 (+0.10), RICE: 25.98 (-0.23), GS: 190.13 (-0.05), FEYE: 33.48 (+0.33), ISIS: 51.45 (+0.37), CYBR: 40.64 (+6.94), GNC: 43.70 (-0.52), HAL: 51.64 (-1.59), EOG: 95.81 (-1.75), AGIO: 86.73 (-0.14), FTNT: 27.09 (-0.07)

Jim Cramer's 'Mad Money' Recap: Winners in the Expectations Game
at The Street - Tue Oct 28, 7:26PM CDT
It's expectations, not the earnings, that determine the direction of a company's stock price, and several companies proved that today, Cramer says.
KSS: 56.43 (-1.48), FEYE: 33.48 (+0.33), CYBR: 40.64 (+6.94), FB: 74.46 (-0.26), GNC: 43.70 (-0.52), HAL: 51.64 (-1.59), AGCO: 44.23 (-0.62), BWLD: 163.35 (+0.35), MAS: 23.17 (-0.02), YHOO: 50.81 (+0.21), WHR: 175.34 (+0.13), VSI: 48.26 (+0.10), SAVE: 78.02 (-0.34), RICE: 25.98 (-0.23), GS: 190.13 (-0.05), PH: 127.30 (-1.27), ISIS: 51.45 (+0.37), CMI: 144.66 (-1.83), EOG: 95.81 (-1.75), AGIO: 86.73 (-0.14), TWTR: 42.07 (-0.47), FTNT: 27.09 (-0.07), BABA: 117.14 (-1.06)

Can Celgene Corporation Stock Motor to $150 Following Earnings?
Sean Williams, The Motley Fool - Motley Fool - Tue Oct 28, 7:03AM CDT
Just as the proverbial American worker stamps their time card on a daily basis and does their job, biotech giant Celgene continues to deliver for shareholders without fail. Last Thursday, Celgene dazzled investors yet again by reporting better...
OMED: 20.97 (-0.33), AGIO: 86.73 (-0.14), CELG: 107.47 (-0.78)

Forget MannKind Corporation: 3 Better Stocks
Motley Fool Staff - Motley Fool - Mon Oct 27, 8:13AM CDT
Source: MannKind. A doubling of Americans diagnosed with diabetes over the coming decade may support demand for  MannKind 's inhalable insulin Afrezza, but that doesn't necessarily mean that MannKind is biotech's best idea. We asked three of...
DXCM: 54.05 (+0.04), NVAX: 5.30 (+0.06), AGIO: 86.73 (-0.14), SNY: 46.58 (+0.02), MNKD: 6.25 (+0.17), CELG: 107.47 (-0.78)

Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014
GlobeNewswire - Mon Oct 27, 7:41AM CDT
Agios Pharmaceuticals, Inc. (Nasdaq:AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today announced that it will host a conference call and live webcast on Friday, November 7, 2014, at 8:00 a.m. EST to report its third quarter 2014 financial results and discuss recent business activities.
AGIO: 86.73 (-0.14)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jumia’s Breakeven Retreat Invites Legal Scrutiny

Updated Category News Views 25

Jumia’s credibility problem did not arrive wearing a disguise. The company spent much of 2026 telling investors that a fourth-quarter Adjusted EBITDA breakeven was still on the table, then discarded that target after reporting third-quarter results. For holders of NYSE:JMIA, that kind of reversal stings because the promise was not some stray talking point; it was...

Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster

Updated Category News Views 81

A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...

Continue Reading
Trinity's Minneapolis Move Signals Freight Momentum

Updated Category News Views 120

A suite change inside downtown Minneapolis is usually wallpaper, but this one carries a little more weight. Trinity Logistics has moved its Minneapolis team from Suite 1850 to Suite 1700 at 100 S. 5th Street, saying the larger space is needed for continued growth and future opportunity. Nobody should confuse an office relocation with a freight-cycle victory lap. Still,...

Continue Reading
Litmus Gets $475 Million as Music Rights Mature Further

Updated Category News Views 107

Music royalties just got another serious pile of institutional money, and Litmus is holding the shovel. The company announced roughly $475 million of new capital commitments from Carlyle and investment funds managed by KKR, a notable vote of confidence in a platform that did not even exist before 2022. This is not some celebrity vanity vehicle buying a famous chorus and...

Continue Reading
Mining's Biodiversity Map Sharpens Location Risks

Updated Category News Views 106

Twelve thousand pins on a map do not settle the mining industry's nature problem, but they do make it much harder to pretend the problem is evenly spread. ICMM's new Global Mining and Metals Biodiversity Dataset overlays 12,000 large-scale formal mining, smelting, refining and processing facilities with ecosystem-condition and conservation indicators. For investors...

Continue Reading
U.S. Patriot's Veteran Hiring Earns a Real National Nod

Updated Category News Views 43

A workforce award can be cheap wallpaper, but this one has some heft. U.S. Patriot, the veteran-founded and veteran-led military goods retailer owned by GALLS, landed on Military Times’ 2026 Best for Vets: Employers list, placing third in retail and first in Kentucky. The recognition covers 250 organizations, and this is U.S. Patriot’s fourth consecutive appearance....

Continue Reading
AMP Tests Debt Market With €1.25 Billion Green Notes

Updated Category News Views 167

Refinancing season has arrived early at Ardagh Metal Packaging, and it is carrying a hefty €1.25 billion price tag. AMP has launched senior secured floating-rate green notes, with proceeds intended to retire two batches of secured debt due in 2028 and leave additional cash on the balance sheet for general corporate purposes, including capital expenditure. This is not...

Continue Reading
Esquire Spotlight Puts Trauma Cleanup Work in Focus

Updated Category News Views 52

A national magazine profile is an odd milestone for a business built around other people’s worst days. David Lesaffre, co-owner and operator of T.A.C.T. 48, T.A.C.T. AZ, and T.A.C.T. Fort Worth, has been featured by Esquire in a piece called “The Trauma Cleaners.” The attention is deserved, frankly, because biohazard remediation is one of those necessary services...

Continue Reading
Star Catcher Powers a Public-Interest Space Bet Ahead

Updated Category News Views 56

A satellite’s battery budget is a rotten place for humanitarian priorities to die. Common Space and Star Catcher are trying to remove that bottleneck through a partnership that is easy to like on principle and still deserves a clear-eyed look on execution. Common Space, a nonprofit developing an independent, community-governed high-resolution satellite constellation,...

Continue Reading
Four Pending Deals Put Shareholder Terms Under Scrutiny

Updated Category News Views 101

Four corporate transactions landed under a legal microscope on November 18, and that is never background noise for shareholders trying to judge whether the paperwork matches the price. Halper Sadeh LLC says it is investigating proposed deals involving WaFd, Personalis, Dana and Baldwin Group for possible federal securities-law violations and/or fiduciary-duty breaches....

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Customer Care: Apivia and SoundHound Unite

Updated Category News Views 247

Transforming Customer Service with AI SoundHound AI (NASDAQ: SOUN) has joined forces with Apivia Courtage, a notable entity within France's AEMA Group, which is recognized as a leading mutual insurance organization. This partnership aims to implement agent-based artificial intelligence into Apivia Courtage's customer service systems through the innovative Amelia 7...

Continue Reading
Taiwan's Bold Pedal Into Sustainability: EUROBIKE 2026

Updated Category News Views 40

Stepping Up the Game at EUROBIKE 2026 Ask any veteran cyclist: The road to innovation is a winding one, and Taiwan's Bicycle Industry seems determined to tackle every curve head-on at EUROBIKE 2026. This isn't just about flashy tech; it's a full-blown commitment to smart, low-carbon mobility—a real 'get on the bike or get left behind' moment. Unveiling the AI-Powered...

Continue Reading
TDI Welcomes Jay Truesdale as New Chief Executive Officer

Updated Category News Views 389

TD International Appoints New Leadership TD International LLC (TDI), a prominent strategic advisory and risk intelligence firm, has announced significant leadership changes with the appointment of Jay Truesdale as Chief Executive Officer. This move marks a pivotal moment for TDI, as it looks to leverage Truesdale's considerable expertise in geopolitics and global markets....

Continue Reading
Canaan Inc. Streamlines Focus on Core Cryptocurrency Market

Updated Category News Views 258

Canaan Inc. Streamlines Focus on Core Cryptocurrency Market Canaan Inc. (NASDAQ: CAN) has recently taken a significant step in refining its business operations. The company is discontinuing its non-core AI semiconductor division to concentrate on its core strengths in the ever-evolving world of cryptocurrency. This strategic decision is aimed at enhancing efficiencies and...

Continue Reading
Ascentage Pharma's Impressive Growth in 2025: A Review

Updated Category News Views 567

Overview of Ascentage Pharma's Interim Results Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) recently announced its interim unaudited financial results for the first half of 2025. The report highlights significant growth, particularly in product sales, and provides exciting updates on ongoing clinical programs and commercial strategies. The company's...

Continue Reading